Researchers target cancer's ability to survive at low oxygen levels
Researchers at the Francis Crick Institute have shed light on how cancer cells survive in the first few hours after being cut off from a supply of oxygen.
Mar 14, 2024
0
11
Researchers at the Francis Crick Institute have shed light on how cancer cells survive in the first few hours after being cut off from a supply of oxygen.
Mar 14, 2024
0
11
A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Mar 14, 2024
0
20
A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published in the New ...
Mar 13, 2024
0
164
Small cell lung cancer (SCLC) is a highly aggressive tumor of the lung that occurs especially in heavy smokers. Due to the rapid spread of this tumor type, most patients can only be treated with chemotherapy with remarkable ...
Mar 13, 2024
0
22
Targeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain ...
Mar 13, 2024
0
89
University of Adelaide researchers now know more about a mysterious gene's role in maintaining healthy DNA—a crucial development that could lead to new treatments for life-threatening illnesses including neurodevelopmental ...
Mar 13, 2024
0
45
A cross-college collaboration is opening new doors in the study of male infertility by breaking down a key step in sperm formation. Isolating the intricacies of meiotic sex chromosome inactivation (MSCI), will now enable ...
Mar 12, 2024
0
16
U.S. military veterans, especially those who served in the Air Force, are at high risk for one of the deadliest skin cancers, melanoma.
Mar 12, 2024
0
0
Women with a type of ovarian cancer known as germ cell tumors have a worse prognosis than men with similar tumors (i.e., testicular cancer). After five years with the disease, 98% of men were alive while the survival rate ...
Mar 12, 2024
0
0
A recent University of Kentucky Markey Cancer Center study published in Proceedings of the National Academy of Sciences uncovers a critical pathway involved in immune evasion by breast cancer cells.
Mar 12, 2024
0
15